For the quarter ending 2025-09-30, OCGN had $5,554K increase in cash & cash equivalents over the period. -$13,007K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -20,051 | -30,089 |
| Depreciation and amortization expense | 950 | 1,836 |
| Non-cash interest expense | 25 | 50 |
| Non-cash lease expense | 324 | 620 |
| Non-cash (income) expense from collaborative arrangements, net | 918 | 1,766 |
| Stock-based compensation expense | 1,975 | 3,730 |
| Other | -9 | -20 |
| Prepaid expenses and other current assets | -795 | 2,708 |
| Lease obligations | - | -596 |
| Accounts payable and accrued expenses | 3,289 | -1,184 |
| Other non-current liabilities | 90 | - |
| Net cash used in operating activities | -12,916 | -30,087 |
| Purchases of property and equipment | 91 | 59 |
| Payment of security deposits | -5 | 131 |
| Net cash used in investing activities | -86 | -190 |
| Issuance of common stock and warrants, net | 18,326 | - |
| Payment of eb-5 loan | 0 | 1,000 |
| Payments from issuance of common stock, net | - | 184 |
| Net cash provided by financing activities | 18,510 | -1,184 |
| Effect of changes in exchange rate on cash and restricted cash | 46 | -36 |
| Net decrease in cash and restricted cash | 5,554 | -31,497 |
| Cash and cash equivalents at beginning of period | 58,821 | - |
| Cash and cash equivalents at end of period | 32,879 | - |
Ocugen, Inc. (OCGN)
Ocugen, Inc. (OCGN)